Skip to main content
. 2021 Mar 22;14:967–981. doi: 10.2147/IJGM.S302012

Figure 3.

Figure 3

Stratified survival analysis of ARRDC3 in ovarian cancer by clinical stage of OS, PFS, PPS. (A and B) Stratified survival analysis of ARRDC3 in ovarian cancer of early stage and late stage of OS, respectively; (C and D) stratified survival analysis of ARRDC3 in ovarian cancer of early stage and late stage of PFS, respectively; (E and F) stratified survival analysis of ARRDC3 in ovarian cancer of early stage and late stage of PPS, respectively.

Notes: Early stage=1+2 stage; late stage=3+4 stage.